Contents

Commonly used abbreviations

23PPV 23-valent pneumococcal polysaccharide vaccine
Ab antibody
ACC Accident Compensation Corporation
AEFI adverse event following immunisation
AFP acute flaccid paralysis
AIDS acquired immunodeficiency syndrome
BCG Bacillus Calmette-Guérin vaccine
BSE bovine spongiform encephalopathy
CARM Centre for Adverse Reactions Monitoring
CRS congenital rubella syndrome
CSF cerebrospinal fluid
DHB district health board
DNA deoxyribonucleic acid
DT diphtheria tetanus vaccine
DTaP paediatric diphtheria, tetanus and acellular pertussis vaccine
DTaP-IPV diphtheria, tetanus, acellular pertussis and inactivated polio vaccine
DTaP-IPV-HepB/Hib diphtheria, tetanus, acellular pertussis, inactivated polio, hepatitis B and Haemophilus influenzae type b vaccine
DTwP diphtheria, tetanus and whole-cell pertussis vaccine
DTwPH diphtheria, tetanus, whole-cell pertussis and Haemophilus influenzae type b vaccine
ESR Institute of Environmental Science and Research
GBS Guillain-Barré syndrome
GP general practitioner
GSK GlaxoSmithKline (New Zealand) Limited
HAV hepatitis A virus
HBcAg hepatitis B core antigen
HBeAg hepatitis B e antigen
HBIG hepatitis B immunoglobulin
HBsAg hepatitis B surface antigen
HBV hepatitis B virus
Hep B hepatitis B
HHE hypotonic-hyporesponsive episode
Hib Haemophilus influenzae type b
HIV human immunodeficiency virus
HPV human papillomavirus
HZ herpes zoster
HZV herpes zoster vaccine
ICD International Classification of Diseases
IG immunoglobulin
IgG immunoglobulin G
IM intramuscular
IMAC Immunisation Advisory Centre
IPV inactivated polio vaccine
IV intravenous
ITP idiopathic thrombocytopenic purpura (also known as immune thrombocytopenia)
IVIG intravenous immunoglobulin
LMC lead maternity carer
MCV4-D quadrivalent meningococcal conjugate vaccine (conjugated to diphtheria toxoid)
Medsafe New Zealand Medicines and Medical Devices Safety Authority
MenCCV meningococcal C conjugate vaccine
MeNZB meningococcal B vaccine
MMR measles, mumps and rubella vaccine
MSD Merck Sharp & Dohme (New Zealand) Limited
NIR National Immunisation Register
NZBS New Zealand Blood Service
NZPSU New Zealand Paediatric Surveillance Unit
OMP outer membrane protein
OPV oral polio vaccine
PCR polymerase chain reaction
PCV7 7-valent pneumococcal conjugate vaccine
PCV10 10-valent pneumococcal conjugate vaccine
PCV13 13-valent pneumococcal conjugate vaccine
PHARMAC Pharmaceutical Management Agency
PHO primary health organisation
PPV pneumococcal polysaccharide vaccine
PRP polyribosylribitol phosphate
PTAC Pharmacology and Therapeutics Advisory Committee
RCT randomised controlled trial
RIG rabies immunoglobulin
RV1 rotavirus vaccine (monovalent)
RV5 rotavirus vaccine (pentavalent)
SC subcutaneous
SUDI sudden unexpected death in infancy
TB tuberculosis
Td adult tetanus diphtheria vaccine
Tdap adult tetanus, diphtheria and acellular pertussis vaccine
TIG tetanus immunoglobulin
TT tetanus toxoid
UK United Kingdom
US United States of America
VAPP vaccine-associated paralytic poliomyelitis
vCJD variant Creutzfeldt-Jakob disease
VV varicella vaccine
VZV varicella zoster virus
WHO World Health Organization
ZIG zoster immunoglobulin